COSMO PHARMACEUTICALS N.V. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 71.6 CHF | -0.69% |
|
+0.28% | +40.67% |
| 04-26 | Cosmo Pharmaceuticals N.V. Announces Executive Changes at the Upcoming Annual General Meeting on 24 May 2024 | CI |
| 04-25 | Cosmo Pharmaceuticals Names New CEO, Chairman | MT |
Chart calendar Cosmo Pharmaceuticals N.V.
9d62efa8373140371dff0.1GVWVA9q7ZAZopBekfzZp747kk0WNHBgUymklh4xeDc.kQx7OkYulKMpl-k1-pOLltZq2wVjAycpHlqd5XtSLwChJG89YQnVqS-T5w~8f627168dfa96201d6de25d56ea8155e
Upcoming events on Cosmo Pharmaceuticals N.V.
Past events on Cosmo Pharmaceuticals N.V.
| 20/03/2024 14:00 | Investor Day |
| 20/03/2024 10:00 | Q4 2023 Earnings Call |
| 20/03/2024 06:00 | Q4 2023 Earnings Release |
| 12/03/2024 | J.P. Morgan Pan-European Small/Mid-Cap CEO Conference |
| 15/01/2024 | ODDO BHF Forum |
| 04/12/2023 | CF&B Communication European Midcap Conference |
| 13/11/2023 | Jefferies London Healthcare Conference |
| 09/10/2023 | Investor Meeting - Day 2 |
| 08/10/2023 | Investor Meeting - Day 1 |
| 26/07/2023 13:00 | Q2 2023 Earnings Call |
| 26/07/2023 06:00 | Q2 2023 Earnings Release |
| 30/05/2023 | Ex-dividend day for final dividend |
| 26/05/2023 11:00 | Annual General Meeting |
| 27/03/2023 | Jefferies Pan-European Mid-Cap Conference |
| 23/03/2023 | Kepler Cheuvreux Swiss Seminar |
| 23/03/2023 13:00 | Q4 2022 Earnings Call |
| 23/03/2023 06:00 | Q4 2022 Earnings Release |
| 12/03/2023 | Berenberg EU Opportunities Conference |
| 28/02/2023 | Credit Suisse London Healthcare Conference |
| 27/11/2022 | Deutsche Börse German Equity Forum |
Past dividends on Cosmo Pharmaceuticals N.V.
| 30/05/2023 | Annual 1.05 EUR |
| 31/05/2022 | Annual 0.95 EUR |
| 28/05/2017 | 1.5 EUR |
| 31/08/2016 | 1.4 EUR |
| 27/04/2014 | Annual 1 EUR |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 65,6 67,9 -3.32% | 62,5 47,1 32.64% | 60,9 53,0 14.94% | 65,1 62,4 4.3% | 102 101 1.31% | 96,7 139 -30.49% |
|
EBITDA Million EUR | Released Forecast Spread | -12,1 -15,4 21.25% | -6,55 -12,7 48.58% | 12,9 9,31 38.99% | 18,5 9,21 100.87% | 41,9 39,4 6.34% | 26,5 67,8 -60.94% |
|
EBIT Million EUR | Released Forecast Spread | -16,6 -20,1 17.44% | -12,3 -17,5 29.63% | 6,91 3,31 108.93% | 11,1 5,31 109.26% | 28,1 28,7 -2.33% | 12,2 56,3 -78.29% |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -17,5 -18,1 3.67% | -21,3 -28,8 26.11% | -6,93 -7,45 6.97% | 24,0 21,0 14.3% | 24,5 23,7 3.19% | 7,61 63,3 -87.97% |
|
Net income Million EUR | Released Forecast Spread | -18,1 -22,1 18.38% | -24,5 -27,6 11.25% | -7,90 -6,47 -22.12% | 21,7 11,3 91.37% | 17,2 21,4 -19.57% | 1,15 34,5 -96.67% |
|
EPS EUR | Released Forecast Spread | -1,20 -1,42 15.4% | -1,67 -1,83 8.71% | -0,55 -0,43 -27.57% | 1,29 0,72 77.89% | 1,05 1,12 -6% | 0,07 0,72 -90.07% |
| Announcement Date | 29/03/19 | 03/04/20 | 26/03/21 | 23/03/22 | 23/03/23 | 20/03/24 |
Quarterly results
| Fiscal Period | December | 2019 S1 | 2019 S2 | 2020 S1 | 2021 S1 | 2022 S1 | 2022 S2 | 2023 S1 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 21,5 27,2 -20.93% | 41,0 23,3 75.91% | 25,9 22,1 17.38% | 28,4 27,9 2.05% | 41,5 38,7 7.26% | 60,6 58,0 4.44% | 43,7 44,6 -2.11% | 131 | 35,8 | 143 | 42,8 | 114 |
|
EBITDA Million EUR | Released Forecast Spread | 8,04 3,70 117.32% | |||||||||||
|
EBIT Million EUR | Released Forecast Spread | -17,2 -8,90 -93.27% | 4,89 -0,90 643.78% | 2,66 -4,20 163.38% | 0,01 0,55 -98.55% | 8,11 3,20 153.38% | 19,9 19,5 2.3% | 7,12 4,90 45.37% | 108 | 11,1 | 94,6 | 15,4 | 66,9 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -22,6 -15,9 -42.26% | 1,32 -8,00 116.44% | -5,33 -8,45 36.91% | -4,67 -6,45 27.64% | 9,09 -1,10 926.27% | 15,4 15,6 -1.38% | 3,67 1,30 182.54% | 95,0 | 67,5 | |||
|
Net income Million EUR | Released Forecast Spread | -20,8 -15,9 -30.7% | -3,71 -6,55 43.33% | -3,02 -8,45 64.32% | -5,74 -6,45 10.99% | 7,90 -1,10 817.82% | 9,33 14,8 -36.97% | 1,49 1,00 48.6% | 68,4 | 48,6 | |||
|
EPS EUR | Released Forecast Spread | -1,41 -1,10 -27.91% | -0,26 -0,50 47.6% | -0,21 -0,55 61.9% | -0,40 -0,43 6.12% | 0,48 -0,06 893.33% | 0,57 0,90 -36.33% | 0,09 0,06 53.33% | 4,26 | 3,02 | |||
| Announcement Date | 30/07/19 | 03/04/20 | 30/07/20 | 30/07/21 | 28/07/22 | 23/03/23 | 26/07/23 | - | - | - | - | - |
More events
Past sector events for Cosmo Pharmaceuticals N.V.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- COPN Stock
- Calendar Cosmo Pharmaceuticals N.V.
